Results 51 to 60 of about 522,036 (354)

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. [PDF]

, 2015
BackgroundBudesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis.AimThe aim of ...
Barrett, Andrew C, Bortey, Enoch, Bosworth, Brian, Forbes, William P, Golden, Pamela L, Gordon, Glenn L, Rolleri, Robert L, Rubin, David T, Sale, Mark E, Sandborn, William J, Zakko, Salam   +10 more
core   +3 more sources

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.

New England Journal of Medicine, 2019
BACKGROUND The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12 and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is unknown.
B. Sands, W. Sandborn, R. Panaccione, C. O’Brien, Hongyan Zhang, J. Johanns, O. Adedokun, Katherine Li, L. Peyrin-Biroulet, G. Van Assche, S. Danese, S. Targan, M. Abreu, T. Hisamatsu, P. Szapary, C. Marano   +15 more
semanticscholar   +1 more source

Two for One: Coexisting Ulcerative Colitis and Crohn’s Disease

Canadian Journal of Gastroenterology, 2002
Three cases of coexisting ulcerative colitis and Crohn’s disease are presented. In the first case, the patient had a long-standing history of ulcerative proctitis before developing Crohn’s colitis.
Grant I Chen, Fred Saibil, Izabella Morava-Protzner   +2 more
doaj   +1 more source

CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis. [PDF]

, 2015
As scientific techniques for the detection of cytomegalovirus (CMV) improve, we are able to detect small amounts of CMV in the mucosal wall. As clinicians, we are unsure how to interpret the results of this novel test.
Goodman, AL, Griffiths, PD, Murray, CD, Watkins, J, Webster, DP   +4 more
core   +1 more source

Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment

Frontiers in Medicine
BackgroundAs the therapeutic landscape for inflammatory bowel disease (IBD) continues to expand, a need exists to understand how patients perceive and value different attributes associated with their disease as well as with current and emerging ...
Elise Schoefs, Séverine Vermeire, Séverine Vermeire, Marc Ferrante, Marc Ferrante, João Sabino, João Sabino, Bram Verstockt, Bram Verstockt, Luisa Avedano, Maria Stella De Rocchis, Magdalena Sajak-Szczerba, Roberto Saldaña, Noortje Straetemans, Noortje Straetemans, Martina Vandebroek, Rosanne Janssens, Isabelle Huys   +17 more
doaj   +1 more source

Molecular mechanism of Huaihuasan in treatment of ulcerative colitis based on network pharmacology and molecular docking

Phytomedicine Plus, 2021
Background: Huaihuasan (HHS) is a Traditional Chinese Medicine formula for ulcerative colitis (UC). However, the pharmacology and molecular mechanism of HHS on ulcerative colitis still unclear.
Yi Wu, Xiaokun Yang, Guiwei Li, Xinqiao Liu   +3 more
doaj   +1 more source

Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis. [PDF]

, 2018
Patients afflicted with ulcerative colitis (UC) are at increased risk of colorectal cancer. While its causes are not fully understood, UC is associated with defects in colonic epithelial barriers that sustain inflammation of the colon mucosa caused by ...
Alexander, Walker, Dilbarova, Rima, Gilligan, John, Hoxha, Kevther, Kossenkov, Andrew, Mullin, James M., Prendergast, George C., Thomas, Sunil, Whittaker, Kelly   +8 more
core   +2 more sources

Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Deutsches Ärzteblatt International, 2020
BACKGROUND Ulcerative colitis is a chronic inflammatory bowel disease with an estimated 150 000 patients in Germany alone. METHODS This review is based on publications about current diagnostic and therapeutic strategies for ulcerative colitis that were
T. Kucharzik, S. Koletzko, K. Kannengiesser, A. Dignass   +3 more
semanticscholar   +1 more source

Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study

BMC Gastroenterology, 2008
Background The cause and pathophysiology of ulcerative colitis are both mainly unknown. We have previously used whole-genome microarray technique on biopsies obtained from patients with ulcerative colitis to identifiy 5 changed mucosal transcripts.
Kvifors Eva, Lindgren Anders, Flach Carl-Fredrik, Eriksson Anders, Lange Stefan   +4 more
doaj   +1 more source

Probiotics for maintenance of remission in ulcerative colitis.

Cochrane Database of Systematic Reviews, 2020
BACKGROUND Ulcerative colitis is an inflammatory condition affecting the colon, with an annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with ulcerative colitis can be put into remission, leaving a group who do not ...
Zipporah Iheozor-Ejiofor, Lakhbir Kaur, M. Gordon, Patricia Anne Baines, V. Sinopoulou, A. Akobeng   +5 more
semanticscholar   +1 more source